Amgen Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AMGN.MX | BIIB | NVS | 0R1F.IL | 068270.KS | 196170.KQ | |
|---|---|---|---|---|---|---|
| Market cap | 4.78T | 37.61B | 311.59B | 137.59B | 49.02T | 14.70T |
| P/E (TTM) | 29.1 | 110.2 | 31.5 | 17.3 | — | — |
| Forward P/E | — | 15.6 | 16.6 | — | — | — |
| Price/book | 17.8 | 2.0 | 8.4 | 4.2 | — | — |
| Dividend yield | 2.14% | — | 2.87% | 4.04% | 0.36% | 0.14% |
| 1-year change | +47.75% | +62.35% | +30.35% | +34.05% | +20.07% | −49.87% |
| Today | +5.60% | +2.22% | +3.59% | +2.89% | +7.50% | +3.68% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All AMGN.MX news ›Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lexicon Pharmaceuticals (LXRX), Amgen (AMGN) and Demant (OtherWILLF)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexicon Pharmaceuticals (LXRX), Amgen (AMGN) and Demant (WILLF). Citi analyst Yigal Nochomovitz maintained a Buy rating on Lexicon Pharmaceuticals yesterday…
Scotiabank Remains a Buy on Amgen (AMGN)
Scotiabank analyst Louise Chen maintained a Buy rating on Amgen today and set a price target of $500.00. According to TipRanks, Chen is a 5-star analyst with an average return of 8.6% and a 54.51% success rate. Chen covers the Healthcare…
Citi Sticks to Its Hold Rating for Amgen (AMGN)
Citi analyst Geoff Meacham maintained a Hold rating on Amgen today and set a price target of $405.00. According to TipRanks, Meacham is a 5-star analyst with an average return of 14.3% and a 58.75% success rate. Meacham covers the…
Rare Disease Treatment Patents after Amgen: Can Claims Cover Untested Genetic Mutations?
4 hours ago 0 This effort does not change any requirements of patent law. The core matter considering the initiative is the following: when a medication against a rare disease has been tested in patients with certain genetic mutations, is…
Amgen Raises 2026 Outlook as Q3 Revenue Grows 8% to $10.4 Billion
Amgen (AMGN ) announced third-quarter 2026 results on November 3, 2026, reporting an 8% year-over-year increase in total revenue to $10.365 billion and raising its full-year revenue and adjusted earnings per share (EPS) outlook. Product…
Amgen Files Q3 2026 10-Q for Quarter Ended September 30
Minichart Amgen Files Q3 2026 10-Q for Quarter Ended September 30 Amgen Inc. (NASDAQ: AMGN) has filed its Form 10-Q for the quarterly period ended September 30, 2026, with the U.S. Securities and Exchange Commission, according to the…
Amgen (NASDAQ:AMGN) Sets New 1-Year High After Better-Than-Expected Earnings
Shares of Amgen Inc. (NASDAQ:AMGN - Get Free Report) reached a new 52-week high during mid-day trading on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $486.25 and last traded…
Amgen (NASDAQ:AMGN) Price Target Raised to $410.00
Amgen (NASDAQ:AMGN - Get Free Report) had its target price upped by equities researchers at Morgan Stanley from $359.00 to $410.00 in a report released on Wednesday, Benzinga reports. The firm presently has an "equal weight" rating on the…
Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
Amgen Beats Q3 Estimates, Raises Full-Year Guidance as Prolia Slides 45%
Amgen Inc (AMGN) delivered a third-quarter beat on both the top and bottom lines and lifted its full-year outlook, but continued erosion in its legacy bone drugs kept the stock from holding its early gains. The Thousand Oaks,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com40
- marketscreener.com36
- theglobeandmail.com20
- themarketsdaily.com13
- seekingalpha.com12
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.